Recursion
Pioneering AI-driven drug discovery to decode biology and radically improve lives
Enterprise·Technical·Powered by Proprietary (Recursion OS)
Key strengths
Massive proprietary biological dataset (>50 petabytes) spanning phenomics, transcriptomics, proteomics, and moreAutomated wet lab with robotics and computer vision generating millions of cell experiments per weekRecursion OS — a continuously improving AI drug discovery and development platformBioHive-2 supercomputer built with NVIDIA for biopharma-scale computeActive clinical pipeline targeting oncology and rare diseases with first-in-class potential
Enterprise pricing
Salt Lake City, USA
Founded 2013
Facts verified against recursion.com on
Get alerts when Recursion changes
Free. We'll email you when pricing, the free tier, API access or open-source status changes.
No ratings yet
Recursion – Technical Documentation Notes
Recursion's platform, Recursion OS, is the primary technical artifact of interest for integration and partnership contexts. The following structural components are documented across Recursion's public technical disclosures:
Platform Components
- Biological Experimentation Layer: Automated wet-lab systems capable of executing up to 2 million experiments per week. Robotics handle assay preparation, imaging, and sample management at scale.
- Data Infrastructure: A proprietary dataset exceeding 50 petabytes, encompassing cellular imaging, genomic, and chemical data. This corpus underpins all downstream ML model training.
- AI/ML Models: Trained on the proprietary dataset to perform tasks including target identification, compound prioritization, and generative de novo chemistry (novel molecule design).
- Dry Lab Integration: Computational pipelines are tightly coupled with wet-lab outputs, forming a continuous feedback loop between experimentation and model refinement.
Key Technical Differentiators
| Capability | Detail |
|---|---|
| Weekly experiment capacity | Up to 2,000,000 |
| Proprietary data volume | 50+ petabytes |
| Compound reduction vs. industry | ~90% fewer required |
| Chemistry approach | Generative de novo (novel structure design) |
| Lab integration | Fully integrated wet + dry automation |
Pipeline
Recursion's internal pipeline is concentrated in oncology and rare disease, with programs at clinical stages.
Alternatives
See all alternatives Alternatives to Recursion
Compare head-to-head:Recursion vs Insilico MedicineRecursion vs Flatiron HealthRecursion vs Hippocratic AI
Browse all 19 healthcare & biotech tools